Extensive Experience and Validation of Polyethylene Glycol Precipitation as a Screening Method for Macroprolactinemia
Authors:
- José Gilberto H VieiraJVJosé Gilberto H Vieira
- Teresinha T TachibanaTTTeresinha T Tachibana
- Leda H ObaraLOLeda H Obara
- Rui M B MacielRMRui M B Maciel
Open Access
- 1 August 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 44 (8) , 1758-1759
Abstract
Serum human prolactin (PRL) is heterogeneous in molecular size, with the 23-kDa monomer being the predominant form in healthy subjects and patients with prolactinomas. From the point of view of molecular size, other circulating forms include the 50-kDa dimer (big-PRL) and the 150- to 170-kDa form (big-big-PRL, or macroprolactin) (1). Recent publications have associated asymptomatic hyperprolactinemia with a predominance of macroprolactin in the circulation; this occurrence appears to be more common than previously thought (2)(3)(4) and can have obvious practical implications. The finding of a predominance of macroprolactinemia can change the focus of the evaluation of a patient, with the possible avoidance of more sophisticated and expensive imaging studies.Keywords
This publication has 5 references indexed in Scilit:
- Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL)Scandinavian Journal of Clinical and Laboratory Investigation, 1995
- Endogenous antibodies against prolactin—a "new" cause of hyperprolactinemiaEuropean Journal of Endocrinology, 1994
- Characterization of a Large Molecular Weight Prolactin in Women with Idiopathic Hyperprolactinemia and Normal Menses*The Journal of Clinical Endocrinology & Metabolism, 1985
- Further evidence that big,big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian functionFertility and Sterility, 1985
- Size Heterogeneity of Human Prolactin in Plasma and Pituitary ExtractsThe Journal of Clinical Endocrinology & Metabolism, 1974